DSM Nutritional Products and Novozymes restate their commitment to the feed market by renewing their strategic alliance agreement. With the renewal of the agreement, the two companies commit to further strengthening and developing their partnership.
The alliance has been highly successful since its beginning in 2001 and the two world leading partners look to launch a number of innovative, market-expanding and promising products over the coming years. The DSM/Novozymes alliance is the Global market leader in feed enzymes.

“We are very pleased to reaffirm our commitment to the feed enzymes alliance with Novozymes. Over the years, the alliance has been a driving force in innovation and expansion of the global markets for animal feed enzymes. We aim for better animal performance with less feed/better raw material utilization, while at the same time reducing environmental phosphates load and contributing to our customers’ profitability by lowering the feed formulation costs and we aim to continue this way”, says Leendert Staal, President of DSM Nutritional Products.

“The alliance of DSM and Novozymes combines world leading competencies and technologies of the two companies to deliver feed enzyme innovation to the customers. We have some very interesting products in our pipeline which have real potential to enable our customers to compensate for the fast rising grain costs. Within the next two years, we expect to launch a new enzyme for corn-soy diets and we have other products lined up for launch over the coming years”, says Novozymes’ Executive Vice President Peder Holk Nielsen, who heads up the company’s Enzymes Business.

The DSM/Novozymes alliance is an exclusive and global agreement. Under the terms of the agreement, Novozymes develops and produces enzymes for animal feed whereas DSM markets and sells the enzymes. The renewed alliance agreement covers the principles of the alliance such as governance structure, supply and distribution of products, intellectual property rights, profit sharing etc. The agreement runs for the next five years.

Leadership through innovation
By adding enzymes to feed, the nutritive value of the diet is improved. The main benefits are faster growth of the animal; better feed utilization; more uniform production; better health status and an improved environment.
Enzymes have traditionally been used in diets of poultry and pigs, however the DSM/Novozymes alliance is currently investigating the benefits of adding enzymes to feed for other types of animals, such as cattle and fish.
Similarly, where feed based on wheat or corn has traditionally been the target for enzymatic improvements, the alliance is now looking at other types of feed and expects to launch an enzyme to improve utilization of corn-soy diets within the next two years.

About Novozymes
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, the company creates tomorrow’s industrial biosolutions, improving its customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes’ bioinnovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s everchanging marketplace. Novozymes’ natural solutions enhance and promote everything from removing trans-fats in food, to advancing biofuels to power the world tomorrow. Its neverending exploration of nature’s potential is evidenced by over 4,500 patents, showing what is possible when nature and technology join forces. More than 4,500 employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow. Novozymes is quoted on the Copenhagen Stock Exchange (NZYMB). Read more at www.novozymes.com

About DSM Nutritional Products
DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The business has sales of about EUR 2 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments. For further company information please visit www.dsmnutritionalproducts.com

About DSM
DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company develops, produces and sells innovative products and services that help improve the quality of life. DSM’s products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics (E&E). DSM’s strategy, named Vision 2010 – Building on Strengths, focuses on accelerating profitable and innovative growth of the company’s specialties portfolio. The key drivers of this strategy are market-driven growth and innovation plus an increased presence in emerging economies. The group has annual sales of over €8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa, Australia and the Americas. More information about DSM can be found at www.dsm.com

For more information:
DSM Nutritional Products
Charlotte Frederiksen

Tel. +41 (0) 61 688 85 14
Fax +41 (0) 61 687 37 16

E-mail: charlotte.frederiksen@dsm.com

Forward-looking statements
This press release contains forward-looking statements. These statements are based on current expectations, estimates and projections of DSM management and information currently available to the company. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that its expectations will be realized. Furthermore, DSM has no obligation to update the statements contained in this press release.